Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,864 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
6-thioguanine--efficacy and safety in chronic active Crohn's disease.
Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF. Herrlinger KR, et al. Among authors: schwab m. Aliment Pharmacol Ther. 2003 Feb 15;17(4):503-8. doi: 10.1046/j.1365-2036.2003.01440.x. Aliment Pharmacol Ther. 2003. PMID: 12622758 Free article.
Remission maintenance by tioguanine in chronic active Crohn's disease.
Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF. Herrlinger KR, et al. Among authors: schwab m. Aliment Pharmacol Ther. 2003 Jun 15;17(12):1459-64. doi: 10.1046/j.1365-2036.2003.01590.x. Aliment Pharmacol Ther. 2003. PMID: 12823147 Free article.
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M. Herrlinger KR, et al. Among authors: schwab m. Aliment Pharmacol Ther. 2004 Jun 15;19(12):1269-76. doi: 10.1111/j.1365-2036.2004.01947.x. Aliment Pharmacol Ther. 2004. PMID: 15191508 Free article.
Adherence to thiopurine treatment in out-patients with Crohn's disease.
Bokemeyer B, Teml A, Roggel C, Hartmann P, Fischer C, Schaeffeler E, Schwab M. Bokemeyer B, et al. Among authors: schwab m. Aliment Pharmacol Ther. 2007 Jul 15;26(2):217-25. doi: 10.1111/j.1365-2036.2007.03365.x. Aliment Pharmacol Ther. 2007. PMID: 17593067 Free article.
6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, Ochsenkühn T, Petritsch W, Knoflach P, Almer S, van der Merwe SW, Herrlinger KR, Seiderer J, Vogelsang H, Mulder CJ; Dutch 6-TG working group. de Boer NK, et al. Among authors: schwab m. Digestion. 2006;73(1):25-31. doi: 10.1159/000091662. Epub 2006 Feb 21. Digestion. 2006. PMID: 16493198 Free article. Review.
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics.
Blank A, Eidam A, Haag M, Hohmann N, Burhenne J, Schwab M, van de Graaf S, Meyer MR, Maurer HH, Meier K, Weiss J, Bruckner T, Alexandrov A, Urban S, Mikus G, Haefeli WE. Blank A, et al. Among authors: schwab m. Clin Pharmacol Ther. 2018 Feb;103(2):341-348. doi: 10.1002/cpt.744. Epub 2017 Jun 21. Clin Pharmacol Ther. 2018. PMID: 28543042 Clinical Trial.
1,864 results